Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
research reports
Marketing
Pharma ESG efforts skew social, PwC study finds
A whopping 77% of pharma ESG efforts over the past 16 months were social, while just 12% were environmental and 11% governance, according to PwC.
Beth Snyder Bulik
Aug 19, 2021 9:30am
J&J's Ponvory late to MS market, but docs still see potential
Aug 10, 2021 11:00am
Pharma's physician payments still deliver big ROI, study finds
Dec 3, 2020 10:05am
Novartis finds employer support matters when treating migraines
Jun 15, 2020 11:39am
Pharma and ad agencies zero in on payer marketing
Aug 29, 2018 10:15am
Migraine study backs treatment expansion
Jul 25, 2018 10:11am
